Asep Medical Holdings Inc. announced the appointments of five new members to its advisory board, all of which take effect immediately and the appointment of Dr. Rob Stenstrom, as Medical Director, effective February 24, 2023. The Company also announces the grant of stock options and restricted share units. ADVISORY BOARD APPOINTMENTS General Wesley K. Clark (U.S. Army ret.) General Wesley K. Clark is a businessman, educator, writer and commentator (most notably with CNN).

He is also a retired U.S. Army officer, serving as the Supreme Allied Commander, Europe of NATO, from 1997 to 2000. He graduated as valedictorian of the class of 1966 at West Point and was awarded a Rhodes Scholarship to the University of Oxford. He spent 38 years in the U.S. Army, receiving many military decorations, honorary knighthoods and the Presidential Medal of Freedom.

General Clark serves as Chairman and CEO of Wesley K. Clark & Associates, a strategic consulting firm for private and public companies Mr. David JohnsonDavid Johnson is the CFO and a director of TLG Acquisition One Corp., a Florida-based strategic business consultancy with expertise in mergers, capital stock exchange, asset acquisition, stock purchase and reorganization. Mr. Johnson has decades of experience with multinational organizations and has specific expertise in mergers and acquisitions and related acquisition integration. He has previously served as a senior managing director responsible for technology investments at Blackstone Group, a leading investment firm.

Before joining the Blackstone Group, Mr. Johnson was Senior Vice President of Strategy at Dell Corporation, responsible for corporate strategy, development and acquisition integration. During his time at Dell, Mr. Johnson oversaw more than a dozen acquisitions totaling over $20 billion and helped transform Dell into an industry leader in software, cloud computing and data security. Before Dell, Mr. Johnson spent 27 years at IBM, holding various corporate development and finance roles, including Vice President of Corporate Development.

Mr. Johnson earned his B.A. in English and his M.B.A. in Finance from Boston College. Mr. J. Bernard RiceMr. Rice is the Chairman of Hush Aerospace, a growing Virginia-based aerospace technology company that fulfils product design, prototyping, analysis and manufacturing of Unmanned Aerial Systems (sUAS) that attain multi-modal mission capabilities across land and water. Mr. Rice is recognized as one of the experts in Information Technology as well as extensive enterprise-level business experience and an impressive senior-level business network essential for strategic business partnerships.

Mr. Rice began his career with IBM in sales in 1983. In 1989, he was appointed Director of Finance, Planning and Administration for IBM's Southern Area. In that role, Mr. Rice was responsible for the staff functions of a $3 billion business and was instrumental in positioning IBM's Southeast Region as the leader in billable services.

Mr. Rice is currently focused on a portfolio of companies with leading capabilities in financial processing, medical cannabis, green energy, accessibility, education and real estate. Dr. Islam Mohamed, BSc MD FRCPCDr. Mohamed is an experienced Radiation Oncologist who began his practice at the BC Cancer Agency in 2000. He completed a Bachelor's degree in Genetics before entering medicine at the University of Alberta.

After his residency in Radiation Oncology at Edmonton'sCross Cancer Institute, he joined BC Cancer, Kelowna and where he specialized in breast, lung, and sarcoma tumour sites. His current practice includes lung, sarcoma and skin tumour sites, with a particular interest in stereotactic radiosurgery. His research interests include integrating stereotactic radiosurgery and immunotherapy, utilizing circulating tumour DNA to guide therapy and detect cancer.

He also focuses on enhancing early cancer detection using new technologies in computed tomography and exosome analysis. Dr. Mohamed serves on the Lung Disease Site Executive of the Canadian Cancer Trials Group (formerly NCI Canada. Mr. Thomas O'ShaughnessyThomas O'Shaughnessy is a seasoned business executive with over twenty-one years of strategy and operations experience with a core focus on health care.

His expertise includes strategic planning, system design, project implementation, and senior-level stakeholder engagement. Mr. O'Shaughnessy is the President of Healthtech - a Nordic Global Company. In this role, he is responsible for driving Healthtech's evolution and growth, developing and executing business strategy and supporting the expansion of Nordic's Meditech practice in the United States.

Thomas was previously a Partner at Deloitte Canada, Health Leader for Western Canada, and National Leader for Clients and Growth for the firm's Health industry practice.Asep Inc.'s Founder, Chairman and CEO, Dr. Robert E. W. Hancock. ASEP INC. APPOINTS DR. ROB STENSTROM AS MEDICAL DIRECTORAsep Inc. announced the appointment of Dr. Rob Stenstrom to the position of Medical Director, effective February 24, 2023. Dr. Stenstrom's initial responsibilities will include critical planning and oversight of clinical studies in preparation for the Company's FDA 510(k) application.

His work provides Asep Inc. with essential emergency room experience, medical research and clinical studies expertise.Dr. Stenstrom completed his medical training at McMaster University and his Family & Emergency Medicine residency at the University of Ottawa. He also holds a Ph.D. in Epidemiology and Biostatistics from McGill University. His research interests include sepsis, septic shock, emergency medicine, resistant bacteria, skin and soft tissue infections and infectious diseases in the emergency department.

He has also been involved in developing guidelines for managing and treating severe sepsis in the emergency department. He is a member of the Canadian Association of Emergency Physicians Critical Care Committee.